Wednesday, September 16, 2026

Revolutionary Blood Test for Colorectal Cancer: 90.4% Accuracy Using AI Technology

A domestic study reveals that blood tests can accurately diagnose colorectal cancer with high precision.

Patients Travel Overseas for Cell Therapies—South Korea Moves to Lower Barriers to Treatment

South Korean patients seek stem cell therapies abroad due to limited options at home, despite high costs and uncertain efficacy.

2NE1’s Sandara Park Takes Legal Action Against Online Trolls: What You Need to Know

2NE1 member Sandara Park takes a stand against online trolls, ready to defend herself from negativity.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

BluEX-C: The Revolutionary Spinal Implant Transforming ACDF Surgery in the U.S.

L&K Biomed expands the clinical application of its cervical height-adjustable cage BluEX-C in the U.S. market.

HLB Panagene to Highlight Potential of Artificial Nucleic Acid PNA in Drug Development in U.S.

HLB Panagene will showcase its proprietary PNA technology and its potential for next-generation drug development at a major U.S. oligonucleotide and peptide conference.

Celltrion Expands Market Presence With Major Tender Wins in Spain and Portugal

Celltrion is accelerating its expansion in Spain and Portugal through major tender wins, rising prescriptions and a strengthened direct-sales strategy across its biosimilar portfolio.

Coreline Soft Integrates Chest CT AI Workflow at St. Joseph’s Health in U.S.

Coreline Soft is expanding its U.S. footprint by integrating its AVIEW chest CT AI into St. Joseph’s Health’s existing PACS, bringing AI-assisted imaging directly into the hospital’s clinical workflow.

How Novosis is Revolutionizing Bone Healing for Difficult Fractures: A Case Study

A clinical case using CGBio's bone substitute Novosis for treating refractory femoral nonunion has been published in an international journal.

AI in Alzheimer’s Care: JLK’s TRACEGENT-AD Secures Medical Device Certification

JLK has secured domestic certification for its AI medical device analyzing MRI signals for Alzheimer's disease abnormalities.

LG’s FDA-Approved 40HT513D Diagnostic Monitor: A Game-Changer for Medical Imaging in 2026

LG Electronics launches a new diagnostic monitor approved by the FDA, expanding its B2B medical display business.

Revolutionizing Drug Development: How LG CNS and Dong-A Socio Group’s AI Platform Cuts Costs and Time

LG CNS supports Dong-A Socio Group in AI-based drug development by building an AI drug development platform with DAI.

Zamenix P: The First AI-Driven Kidney Stone Surgery Robot Approved by FDA – A Game Changer in Minimally Invasive Surgery?

ROEN Surgical secures FDA approval for its kidney stone surgery robot, targeting the U.S. medical device market.

International Pharmaceutical Launches Exduo Plus – The New Triple-Combination Hypertension Treatment for 2026

International Pharmaceutical launches a new hypertension treatment combining three ingredients, expanding its cardiovascular product line.

Samsung Bioepis, Built on Biosimilars, Expands Growth Strategy Into Novel Drugs

Samsung Bioepis is pursuing a two-track growth strategy that combines global biosimilar expansion with next-generation novel drug development, including ADC therapies.

Shouting and flailing in your sleep? MRI may help identify patients at high risk for Parkinson’s

Neuromelanin-sensitive MRI may help identify REM sleep behavior disorder patients at higher risk of Parkinson’s disease who should undergo further PET evaluation.

Single-Port Robotic Surgery Shows Strong Results for Upper Tract Urothelial Cancer, Cuts Operating Time by 52 Minutes

A Seoul St. Mary’s Hospital study found that single-port robotic retroperitoneal surgery for upper tract urothelial cancer shortened operating time by 23.5%, reduced blood loss and showed comparable oncologic safety to conventional multi-port surgery.

Kangstem Biotech CSO Professor Kang Kyung-sun Confirms Therapeutic Potential of Vascularized Artificial Liver

Kangstem Biotech’s CSO Professor Kang Kyung-sun developed a vascularized artificial liver that showed therapeutic effects in animal models, offering potential for future transplant alternatives.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.